There are more than 46,000 newly diagnosed cases of lung cancer in the UK each year, according to Cancer Research UK.
And although 89% of cases are preventable, lung cancer accounts for roughly 36,000 deaths a year.
But there are some simple lifestyle changes that can help people avoid the potentially deadly disease.
The obvious one is to quit smoking – which is the best way to prevent lung cancer – but the NHS also recommends making some simple diet changes.
Oncimmune Plc (LON:ONC) is a leader in the development, manufacture and marketing of personalised immunodiagnostics for the screening, detection and care of cancer. The Group has pioneered the development of autoantibody tests that can detect cancer up to four years earlier than other methods and can be applied to a very wide range of solid tumour types. The Company’s first product, EarlyCDT®-Lung, was launched in 2012, as a CLIA test in the USA and since then over 156,000 commercial tests have been sold. EarlyCDT®-Lung is available through physicians in the US and also privately in the UK, Europe & Asia. EarlyCDT®-Lung is being used in the largest ever randomised trial for the early detection of lung cancer using biomarkers, the National Health Service (NHS) Scotland ECLS study of 12,210 high-risk smokers. EarlyCDT®-Liver launched in May 2018 and further tests are in development.
